ExBRAC- Expressive Writing in Breast Cancer

Region Skane

Status: Not yet enrolling

Conditions: Breast Cancer

Treatments: Behavioral: Expressive Writing

Study type: Interventional

Funder types: Other

Identifiers

NCT07298980

2023-2888

Details and patient eligibility

About

The study is a randomized trial designed to examine whether an "expressive writing" intervention can affect the quality of life in patients recently diagnosed with breast cancer. The method "expressive writing" consists of writing about the breast cancer or other related subjects during 20 minutes, once a week for four consecutive weeks. The impact on quality of life will be assessed by having participants complete questionnaires at three different time points during the study. The questionnaire will be developed using a clinimetric approach, based on semi-structured interviews with breast cancer patients. The themes emerging from these interviews will be used to formulate the questions. Additionally, well-known quality-of-life measurement instruments and registry data with clinically relevant information-such as tumor stage and treatment-will be incorporated.

Enrollment: 272 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Planned for surgery of breast cancer without neoadjuvant treatment

Exclusion criteria

• Not able to understand Swedish
• Previous breast cancer

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

272 participants in 2 patient groups

Expressive Writing

Experimental group

Description:

Expressive writing for 20 minutes, once a week, for 4 consecutive weeks. The intervention is done in addition to standard care.

Treatment:

Behavioral: Expressive Writing

Control group

No Intervention group

Description:

No intervention. Treatment according to standard care.